Free Trial

Atyr PHARMA (ATYR) News Today

Atyr PHARMA logo
$4.28 +0.41 (+10.47%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ATYR Latest News

High Growth Tech Stocks in the US to Watch This May 2025
Atyr PHARMA INC stock logo
Jane Street Group LLC Invests $720,000 in Atyr PHARMA INC (NASDAQ:ATYR)
Jane Street Group LLC bought a new position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 199,006 shares of the company's stock, valued at approximately $720,000. Jane Street Group LLC owned 0.24% o
Atyr PHARMA INC stock logo
Woodline Partners LP Invests $6.09 Million in Atyr PHARMA INC (NASDAQ:ATYR)
Woodline Partners LP purchased a new position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,683,000 shares of the company's stock, valued
Atyr PHARMA INC stock logo
HC Wainwright Reaffirms Buy Rating for Atyr PHARMA (NASDAQ:ATYR)
HC Wainwright reaffirmed a "buy" rating and issued a $35.00 price objective on shares of Atyr PHARMA in a report on Monday.
Atyr PHARMA INC stock logo
OMERS ADMINISTRATION Corp Takes Position in Atyr PHARMA INC (NASDAQ:ATYR)
OMERS ADMINISTRATION Corp bought a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 138,000 shares of the company's stock, valued at approxima
Atyr PHARMA INC stock logo
Tang Capital Management LLC Invests $2.43 Million in Atyr PHARMA INC (NASDAQ:ATYR)
Tang Capital Management LLC purchased a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 671,134 shares of the company's stock
Atyr PHARMA INC stock logo
Point72 Asset Management L.P. Purchases New Stake in Atyr PHARMA INC (NASDAQ:ATYR)
Point72 Asset Management L.P. purchased a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,883,197 shares of the company's stock, valued at appr
Atyr PHARMA INC stock logo
Dimensional Fund Advisors LP Makes New $881,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR)
Dimensional Fund Advisors LP purchased a new position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 243,369 shares of the compan
Atyr PHARMA INC stock logo
Octagon Capital Advisors LP Makes New $3.26 Million Investment in Atyr PHARMA INC (NASDAQ:ATYR)
Octagon Capital Advisors LP bought a new position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 900,000 shares of the company's stock, valued at approximately $3,258,000.
Atyr PHARMA INC stock logo
Integral Health Asset Management LLC Buys New Stake in Atyr PHARMA INC (NASDAQ:ATYR)
Integral Health Asset Management LLC acquired a new position in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 375,000 shares of the company's stock, valued at approximate
Atyr PHARMA INC stock logo
J. Goldman & Co LP Buys New Shares in Atyr PHARMA INC (NASDAQ:ATYR)
J. Goldman & Co LP bought a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 300,131 shares of the company's stock, valued at approximately $1,086,000. J.
Atyr PHARMA INC stock logo
Q3 Earnings Forecast for Atyr PHARMA Issued By HC Wainwright
Atyr PHARMA INC (NASDAQ:ATYR - Free Report) - HC Wainwright cut their Q3 2025 earnings per share estimates for Atyr PHARMA in a report issued on Thursday, May 8th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of ($0.19) per share for the quarter, down from
Atyr PHARMA INC stock logo
Leerink Partnrs Estimates Atyr PHARMA Q2 Earnings
Atyr PHARMA INC (NASDAQ:ATYR - Free Report) - Equities research analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Atyr PHARMA in a report issued on Wednesday, May 7th. Leerink Partnrs analyst F. Khurshid expects that the company will earn ($0.17) per share for the quarter. Leerin
Atyr PHARMA INC stock logo
Barclays PLC Acquires New Position in Atyr PHARMA INC (NASDAQ:ATYR)
Barclays PLC bought a new position in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 159,407 shares of the company's stock, valued at approximately $577,000. Barclays PLC
Atyr PHARMA INC stock logo
Alyeska Investment Group L.P. Invests $4.63 Million in Atyr PHARMA INC (NASDAQ:ATYR)
Alyeska Investment Group L.P. acquired a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,278,441 shares of the company's stock, valued at
Atyr PHARMA INC stock logo
Wells Fargo & Company MN Invests $383,000 in Atyr PHARMA INC (NASDAQ:ATYR)
Wells Fargo & Company MN purchased a new position in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 105,769 shares of the company's stock, valued at a
Atyr PHARMA INC stock logo
Atyr PHARMA INC (NASDAQ:ATYR) Receives Consensus Recommendation of "Buy" from Brokerages
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) has received an average recommendation of "Buy" from the seven research firms that are currently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to th
Atyr PHARMA INC stock logo
Atyr PHARMA INC (NASDAQ:ATYR) Short Interest Up 20.6% in April
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 10,030,000 shares, an increase of 20.6% from the March 31st total of 8,320,000 shares. Approximately 11.7% of the company's stock are sold short. Based on an average daily trading volume, of 1,390,000 shares, the short-interest ratio is currently 7.2 days.
Atyr PHARMA INC stock logo
FY2026 EPS Estimates for Atyr PHARMA Decreased by Analyst
Atyr PHARMA INC (NASDAQ:ATYR - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for Atyr PHARMA in a report issued on Tuesday, April 29th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings per sha
Atyr PHARMA INC stock logo
Ally Bridge Group NY LLC Invests $2.53 Million in Atyr PHARMA INC (NASDAQ:ATYR)
Ally Bridge Group NY LLC acquired a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 699,730 shares of the company's stock, valued at approximately $2,533,000. Atyr PHARMA mak
Atyr PHARMA INC stock logo
248,000 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Acquired by 683 Capital Management LLC
683 Capital Management LLC bought a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 248,000 shares of the company's stock, valued at
Atyr PHARMA INC stock logo
Adage Capital Partners GP L.L.C. Buys New Shares in Atyr PHARMA INC (NASDAQ:ATYR)
Adage Capital Partners GP L.L.C. purchased a new position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,000,000 shares of the company's stock, v
Atyr PHARMA INC stock logo
JPMorgan Chase & Co. Boosts Stake in Atyr PHARMA INC (NASDAQ:ATYR)
JPMorgan Chase & Co. raised its position in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) by 467.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 178,532 shares of the company's stock after bu
Atyr PHARMA INC stock logo
Atyr PHARMA (ATYR) Projected to Post Earnings on Thursday
Atyr PHARMA (NASDAQ:ATYR) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-atyr-pharma-inc-stock-1/)
Atyr PHARMA INC stock logo
Geode Capital Management LLC Buys Shares of 891,407 Atyr PHARMA INC (NASDAQ:ATYR)
Geode Capital Management LLC bought a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 891,407 shares of the company's
Atyr PHARMA INC stock logo
Renaissance Technologies LLC Makes New $2.08 Million Investment in Atyr PHARMA INC (NASDAQ:ATYR)
Renaissance Technologies LLC acquired a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 574,455 shares of the company's stock, valued at a
Atyr PHARMA INC stock logo
Atyr PHARMA (ATYR) to Release Quarterly Earnings on Thursday
Atyr PHARMA (NASDAQ:ATYR) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-atyr-pharma-inc-stock-1/)
Piper Sandler Reaffirms Their Buy Rating on aTyr Pharma (ATYR)
Atyr PHARMA INC stock logo
American Century Companies Inc. Makes New $319,000 Investment in Atyr PHARMA INC (NASDAQ:ATYR)
American Century Companies Inc. acquired a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 88,112 shares of the company's stock, valued at approximately $319,000
Atyr PHARMA INC stock logo
14,666,600 Shares in Atyr PHARMA INC (NASDAQ:ATYR) Acquired by Federated Hermes Inc.
Federated Hermes Inc. acquired a new stake in Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 14,666,600 shares of the company's stock, valued at approximately
Atyr PHARMA INC stock logo
Atyr PHARMA INC (NASDAQ:ATYR) Given Consensus Rating of "Buy" by Brokerages
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the stock, Marketbeat reports. Six analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation
Atyr PHARMA INC stock logo
Tikvah Management LLC Acquires Shares of 2,460,833 Atyr PHARMA INC (NASDAQ:ATYR)
Tikvah Management LLC acquired a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,460,833 shares of the company's stock, valued at
Atyr PHARMA INC stock logo
Knott David M Jr Purchases Shares of 308,133 Atyr PHARMA INC (NASDAQ:ATYR)
Knott David M Jr acquired a new stake in shares of Atyr PHARMA INC (NASDAQ:ATYR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 308,133 shares of the company's stock, valued at
Atyr PHARMA INC stock logo
Short Interest in Atyr PHARMA INC (NASDAQ:ATYR) Rises By 31.6%
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 6,920,000 shares, a growth of 31.6% from the February 28th total of 5,260,000 shares. Currently, 8.1% of the company's stock are short sold. Based on an average daily trading volume, of 1,260,000 shares, the short-interest ratio is currently 5.5 days.
Atyr PHARMA INC stock logo
Atyr PHARMA INC (NASDAQ:ATYR) Short Interest Update
Atyr PHARMA INC (NASDAQ:ATYR - Get Free Report) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 5,260,000 shares, a growth of 20.9% from the February 13th total of 4,350,000 shares. Approximately 6.5% of the shares of the stock are short sold. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is currently 4.6 days.
Get Atyr PHARMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATYR and its competitors with MarketBeat's FREE daily newsletter.

ATYR Media Mentions By Week

ATYR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATYR
News Sentiment

1.24

1.03

Average
Medical
News Sentiment

ATYR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATYR Articles
This Week

5

2

ATYR Articles
Average Week

Get Atyr PHARMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATYR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ATYR) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners